Northwestern Mutual Wealth Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Hold
0
-$1 3712
2023
Q3
Sell
-1
Closed -$4.29K 3265
2023
Q2
$2.99K Buy
+1
New +$3.47K ﹤0.01% 2906
2023
Q1
Hold
0
3332
2022
Q4
Hold
0
3311
2022
Q3
Hold
0
3453
2022
Q2
Hold
0
3536
2022
Q1
Hold
0
3469
2021
Q4
Hold
0
3389
2021
Q3
Hold
0
3262
2021
Q2
Hold
0
3192
2021
Q1
Hold
0
3000
2019
Q4
Hold
0
2658
2019
Q3
Hold
0
2723
2018
Q2
Hold
0
2519
2018
Q1
Hold
0
2459

Other funds holding SEEL

Northwestern Mutual Wealth Management's SEEL Position: Q4 2023 in Review

Northwestern Mutual Wealth Management held its Seelos Therapeutics, Inc. Common Stock (SEEL) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3712.

Northwestern Mutual Wealth Management first reported a position in SEEL in Q2 2023 and has held it in 1 quarter since. The position peaked at $2.99K in Q2 2023. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.

  • Northwestern Mutual Wealth Management held 0 shares of Seelos Therapeutics, Inc. Common Stock worth $0 as of Q4 2023.
  • Northwestern Mutual Wealth Management left its Seelos Therapeutics, Inc. Common Stock share count unchanged in Q4 2023.
  • Seelos Therapeutics, Inc. Common Stock made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q4 2023, its #3712 holding.
  • Northwestern Mutual Wealth Management first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2023 and has held it in 1 quarter since.
  • Northwestern Mutual Wealth Management's Seelos Therapeutics, Inc. Common Stock position peaked at $2.99K in Q2 2023.
  • 32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2023, filed 13 Feb 2024.